Atlas
Market PulseSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › PFIZER

PFIZER

Pfizer Limited
Small-capHealthcare ↗

What the six lenses say about PFIZER — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹4590.1
2026-07-10
VWAP · 1Y anchor
₹5054
-9.2% from VWAP
P/E · TTM
—
no TTM EPS
52-week range
13%
position low→high
RSI(14)
55
momentum

Own sector index

Healthcare ↗
Overweight

1M

+5.5%

3M

+14.9%

1Y

+12.8%

Breadth >EMA21

68%

How PFIZER’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
2.5
avg conviction decile
Leadership
0/2
active lenses · Tech & Flow
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Small-cap cohortDRaw
TechnicalD315›

The actual numbers

Price vs VWAP (1y)-9.2%
EMA trend stackDown · 21<50<200
Price vs 200-EMA-4.3%
Price vs 50-EMA+0.0%
RSI(14)55
RS vs Nifty 500 · 3M-9.0%
RS vs sector · 3M-20.6%
52-week range13%
Volume vs 30d avg1.15×
Volume vs 60d avg1.38×
ATR(14) · volatility114.2
Bollinger width · vol contraction0.042
FundamentalD760›

The actual numbers

Return on equity (ROE)19.8%
Return on capital (ROCE)27.2%
Operating margin37.9%
Net margin27.5%
Revenue growth · YoY+0.8%
EPS growth · YoY+8.6%
Debt / equity0.00×

Full 8-quarter history in the financials table below.

ValuationD740›

The actual numbers

52-week range13%
CatalystD116›

The actual numbers

Earnings & momentum19
Capital actions8
Governance18

Every filing in the corporate-announcements panel below.

FlowD242›

The actual numbers

Promoter holding63.9%
Delivery · 30d avg53.0%
Up/down-day asymmetry-6.9pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D3 + D2 ) ÷ 2 = 2.5(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Below threshold
18
Conviction score 18/100 · avg-decile strength 2.5/10
Conviction score18/100›
TechnicalD3›
FundamentalD7›
ValuationD7›
CatalystD1›
FlowD2›

Policy

Government policy · Healthcare

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+0.9pp
+4.3pp
-2.1pp
-5.4pp
+0.9pp
-10.7pp
Nifty 500
Broad-market baseline
+0.5pp
+4.2pp
-2.7pp
-9.0pp
-4.1pp
-14.5pp
Sector
Own-sector index
—
—
-4.4pp
-20.6pp
-16.9pp
-29.0pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

PFIZER daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
4590.10+58.00

Relative strength

RS vs baseline · rebased to 100

PFIZER ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
91.05+0.47

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

No quarterly financials available.

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 5 Jun '26
    MEDIUMgovernance
    Disclosure under SEBI Takeover Regulations
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 12 May '26
    LOWgovernance
    Change in Management
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 12 May '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 12 May '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 24 Apr '26
    LOWgovernance
    Delay/default in the payment of fines/penalties/dues etc. to authority
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 Apr '26
    HIGHearnings
    Reply to Clarification- Financial results
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 31 Mar '26
    LOWgovernance
    Change in Management
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 9 Feb '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 20 Jan '26
    LOWgovernance
    Change in Management
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 7 Jan '26
    HIGHearnings
    Clarification - Financial Results
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 28 Dec '25
    LOWgovernance
    Action(s) initiated or orders passed
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 24 Dec '25
    LOWgovernance
    Action(s) taken or orders passed
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 23 Dec '25
    LOWgovernance
    Change in Management
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 19 Dec '25
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 19 Dec '25
    LOWgovernance
    Arrangements for strategic, technical, manufacturing, or marketing tie up
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds PFIZER

Mutual funds holding PFIZER (10)

FundWeightAUM ₹crGrade
Nippon India Small Cap Gr0.68%78,407
Nippon India Small Cap Dir Bns0.68%78,407
Nippon India Small Cap Gr Bns0.68%78,407
Quant Small Cap Gr1.32%31,774
UTI Mid Cap Reg Gr0.86%12,122
Nippon India Pharma Bns1.56%9,044
Nippon India Pharma Gr1.56%9,044
ICICI Pru Smallcap Instl Gr1.71%8,949
ICICI Pru Smallcap Gr1.71%8,949
ICICI Pru Pharma Healthcare Diag Gr1.86%6,454

ETFs holding PFIZER (1)

ETFWeightGrade
Mirae Asset Nifty 500 Healthcare ETF0.55%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Healthcare